Abstract:Schistosoma japonicum (S. japonicum) is one of the etiological agents of schistosomiasis, a widespread zoonotic parasitic disease. However, the mechanism of the balanced co-existence between the host immune system and S. japonicum as well as their complex interaction remains unclear. In this study, 16S rRNA gene sequencing, combined with metagenomic sequencing approach as well as ultraperformance liquid chromatography–mass spectrometry metabolic profiling, was applied to demonstrate changes in the gut microbiome community structure during schistosomiasis progression, the functional interactions between the gut bacteria and S. japonicum infection in BALB/c mice, and the dynamic metabolite changes of the host. The results showed that both gut microbiome and the metabolites were significantly altered at different time points after the infection. Decrease in richness and diversity as well as differed composition of the gut microbiota was observed in the infected status when compared with the uninfected status. At the phylum level, the gut microbial communities in all samples were dominated by Firmicutes, Bacteroidetes, Proteobacteria, and Deferribacteres, while at the genus level, Lactobacillus, Lachnospiraceae NK4A136 group, Bacteroides, Staphylococcus, and Alloprevotella were the most abundant. After exposure, Roseburia, and Ruminococcaceae UCG-014 decreased, while Staphylococcus, Alistipes, and Parabacteroides increased, which could raise the risk of infections. Furthermore, LEfSe demonstrated several bacterial taxa that could discriminate between each time point of S. japonicum infection. Besides that, metagenomic analysis illuminated that the AMP-activated protein kinase (AMPK) signaling pathway and the chemokine signaling pathway were significantly perturbed after the infection. Phosphatidylcholine and colfosceril palmitate in serum as well as xanthurenic acid, naphthalenesulfonic acid, and pimelylcarnitine in urine might be metabolic biomarkers due to their promising diagnostic potential at the early stage of the infection. Alterations of glycerophospholipid and purine metabolism were also discovered in the infection. The present study might provide further understanding of the mechanisms during schistosome infection in aspects of gut microbiome and metabolites, and facilitate the discovery of new targets for early diagnosis and prognostic purposes. Further validations of potential biomarkers in human populations are necessary, and the exploration of interactions among S. japonicum, gut microbiome, and metabolites is to be deepened in the future.

[Proteomic Analysis of Adult Schistosoma Japonicum Treated with Praziquantel].

Comparative Immunomic Analysis of Schistosoma Japonicum Soluble Egg Antigens Reacting with Patient Sera Before and after Praziquantel Treatment

Effect of praziquantel on the differential expression of mouse hepatic genes and parasite ATP binding cassette transporter gene family members during Schistosoma mansoni infection

Comparative Analysis of Schistosoma Japonicum from Pairing-to-Sexual Maturation Based on Itraq Proteomics

Praziquantel promotes protection against Schistosoma japonicum infection in mice

[Screening and identification of differentially expressed proteins between adult female and male worms of Schistosoma japonicum]

Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII.

In vivo praziquantel efficacy of Schistosoma japonicum over time: A systematic review and meta-analysis

Experiment Study Susceptibility of Schistosoma Japonicum in Cercariae Stage to Praziquantel Around Poyang Lake Area

Excretory/Secretory Proteome of the Adult Developmental Stage of Human Blood Fluke, Schistosoma Japonicum

Comparison of the Therapeutic Efficacy and Side Effects of a Single Dose of Levo-Praziquantel with Mixed Isomer Praziquantel in 278 Cases of Schistosomiasis Japonica

Transcriptome Profilings of Female Schistosoma Japonicum Reveal Significant Differential Expression of Genes after Pairing

Proteomic Analysis on Cercariae and Schistosomula in Reference to Potential Proteases Involved in Host Invasion of Schistosoma Japonicum Larvae

Effects of IL-18 on immunoregulation in mice infected with Schistosoma japonica following praziquantel treatment

Changes of Ultrasonography and Two Serum Biochemical Indices for Hepatic Fibrosis in Schistosomiasis Japonica Patients One Year after Praziquantel Treatment

Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica

Diagnostic Efficacy of Plasma-Based Real-Time PCR for Schistosomiasis Japonica in Mice before and after Treatment with Praziquantel

Combined transcriptomics and proteomics to identify differential proteins involved in the immune response to the parasite schistosoma japonicum in snail hosts pre-infected with exorchis sp

New Perspectives on Host-Parasite Interplay by Comparative Transcriptomic and Proteomic Analyses of Schistosoma Japonicum

Alterations of Gut Microbiome and Metabolite Profiling in Mice Infected by Schistosoma japonicum

Insight into the Host–parasite Interplay by Proteomic Study of Host Proteins Copurified with the Human Parasite, Schistosoma Japonicum